Ultragenyx

sale transaction MA deal changing hands money money changing hands
Pharma

Ultragenyx cashes in a pair of FDA review vouchers for $413M

Hot off a pair of key FDA approvals this summer, Ultragenyx has wasted little time cashing in on a pair of priority review vouchers it earned.
Fraiser Kansteiner Oct 14, 2026 4:19pm
Sunrise over foggy forest in Tuscany Italy

FDA approves Ultragenyx gene therapy after prior rejection

Sep 17, 2026 4:50pm
An artists impression of DNA The DNA appears to be made up of glowing orbs and appears on a blue background

Ultragenyx, after FDA speed bump, lands 1st gene therapy nod

Aug 19, 2026 10:33pm
Henrietta Lacks

Novartis settles lawsuit with estate of Henrietta Lacks

Feb 24, 2026 10:20am
FDA
Favicon Fierce Biotech

FDA plans real-time release of drug rejection letters

Sep 4, 2025 1:45pm
FDA stop sign

FDA snubs Ultragenyx gene therapy over manufacturing issues

Jul 14, 2025 10:16am